Quality Digest
Published: Tuesday, June 21, 2005 - 22:00 The company’s Phase 1 Express project allows pharmaceutical companies to form clinical trials and includes preformulation, formulation, analytical R&D, QC release, stability, manufacturing, packaging and labeling of clinical supplies for Phase 1 development. “Timing is a critical factor on the road to successful clinical study,” says Phil Meeks, Azopharma CEO. “We can now assist our customers in all phases of drug development for Phase 1 clinical supplies. Our Phase 1 Express will raise the bar in the industry and bring unsurpassed speed to the development of clinical materials.” For more information, visit www.azopharma.com. For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.
FDA Compliance Chemir Pharma Services Changes Name to Azopharma
Chemir Pharma Services recently changed its name to Azopharma in response to its extensive growth and commitment as a contract pharmaceutical services provider. Azopharma is a FDA-registered and cGMP-compliant research and development organization that supports the development and commercialization of pharmaceutical, biotech and medical devices.
About The Author
Quality Digest
© 2023 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute, Inc.
